top
Search terms
Results 51 - 60 of 137 - ordered by :
Pages: 1 ... 3 4 5 6 7 8 9 ... 14
Ehjcvp

The alterations of the vessel wall tension and flow rate that are associated with increased visit-to-visit BP variability may initiate atherosclerosis formation due to unique signals generated by ...

European Heart Journal - Cardiovascular Pharmacotherapy, Correspondence, Michiaki Nagai, Keigo Dote, Masaya Kato, Shota Sasaki, Noboru Oda

Date : 26/12/2016 Item size : 127748 bytes
Ehjcvp

Pericarditis is an important cause of chest pain leading to frequent emergency room visits and reduced quality of life. Colchicine reduced the incidence rate of recurrent pericarditis in patients ...

European Heart Journal - Cardiovascular Pharmacotherapy, ORIGINAL ARTICLE, Shiv Kumar Agarwal, Srikanth Vallurupalli, Barry F. Uretsky, Abdul Hakeem

Date : 01/04/2015 Item size : 280471 bytes
Ehjcvp

Dear Editor, We thank Dr Martinez-Martin et al. for their interest in our article.1 In their letter, the authors question if SGLT1 has no compensatory role during the inhibition of SGLT2 We referred ...

European Heart Journal - Cardiovascular Pharmacotherapy, CORRESPONDENCE, Anne E. de Leeuw, Rudolf A. de Boer

Date : 30/05/2016 Item size : 103449 bytes
Ehjcvp

Abstract Renal sympathetic denervation (RDN) has been proposed as a new treatment modality in patients with apparent treatment-resistant hypertension (TRH), a condition defined as persistent blood ...

European Heart Journal - Cardiovascular Pharmacotherapy, REVIEW, Sverre E. Kjeldsen, Fadl Elmula M. Fadl Elmula, Ingrid Os, Alexandre Persu, Yu Jin, Jan A. Staessen

Date : 01/01/2015 Item size : 349851 bytes
Ehjcvp

The decreased risk of AF remained significant after adjusting for age, sex, and comorbidities with a hazard ratio (95% CI) of 0.76 (0.571.00), P0.047 associated with TZD treatment compared with other ...

European Heart Journal - Cardiovascular Pharmacotherapy, Original Article, Jannik Langtved Pallisgaard, Tommi Bo Lindhardt, Laila Staerk, Jonas Bjerring Olesen, Christian Torp-Pedersen, Morten Lock ...

Date : 08/11/2016 Item size : 223886 bytes
Ehjcvp

In this issue of European Heart Journal Cardiovascular Pharmacology a substudy of the Italian EYESHOT Registry focused on medically managed patients is published.1 In it, the authors describe the ...

European Heart Journal - Cardiovascular Pharmacotherapy, EDITORIAL, Héctor Bueno

Date : 01/07/2015 Item size : 219771 bytes
Ehjcvp

Abstract Cardiovascular disease is the leading cause of morbidity and mortality among patients with diabetes, underscoring the importance of choosing anti-diabetic drugs that do not increase ...

European Heart Journal - Cardiovascular Pharmacotherapy, REVIEWS, R. Kumar, D. M. Kerins, T. Walther

Date : 01/01/2016 Item size : 517106 bytes
Ehjcvp

[...]year of a journal Since they are selected due to their known knowledge and good reputation, my friends expected that their fees would be sky high. Laura Fortuna and co-workers from USA ...

European Heart Journal - Cardiovascular Pharmacotherapy, EDITORIALS, Stefan Agewall

Date : 01/01/2016 Item size : 108210 bytes
Ehjcvp

The primary trial endpoint is the composite of death, MI, hospitalization for unstable angina, urgent percutaneous coronary intervention, and urgent coronary artery bypass grafting. Introduction ...

European Heart Journal - Cardiovascular Pharmacotherapy, Original Article, Otto Hartman, Petri T. Kovanen, Jukka Lehtonen, Kari K. Eklund, Juha Sinisalo

Date : 08/11/2016 Item size : 295073 bytes
Ehjcvp

ApoA-I Milano (apoA-IM) is a natural variant of human apoA-I identified in individuals in northern Italy, which results from the replacement of arginine by cysteine at position 173 of the apoA-I ...

European Heart Journal - Cardiovascular Pharmacotherapy, INVITED EDITORIAL, Antonio J. Vallejo-Vaz, Kausik K. Ray

Date : 01/01/2016 Item size : 167390 bytes